Cargando…
Launching a CDMO in Brazil aiming to develop biopharmaceuticals for clinical trials
The innovation timeline is expensive, risky, competitive, time-consuming, and labor-intensive. In order to overcome such challenges and optimize financial resources, pharmaceutical companies nowadays hire contract development and manufacturing organizations (CDMO) to help them. Based on the experien...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Centro de Estudos de Venenos e Animais Peçonhentos (CEVAP/UNESP)
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9171928/ https://www.ncbi.nlm.nih.gov/pubmed/35721790 http://dx.doi.org/10.1590/1678-9199-JVATITD-2022-0017 |